FRESENIUS KABI ONCOLOGY LTD
FRESENIUS KABI ONCOLOGY LTD (India) holds 1 active US FDA Type II Drug Master File and 27 inactive and has DMF or CEP filings on record for 27 active ingredients. 30 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “FRESENIUS KABI ONCOLOGY LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/fresenius-kabi-oncology-ltd
Overview
FRESENIUS KABI ONCOLOGY LTD is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering BELINOSTAT.
Core services & business areas
Therapeutic areas
Active ingredients with DMF or CEP filings
Substances for which FRESENIUS KABI ONCOLOGY LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
FRESENIUS KABI ONCOLOGY LTD holds 1 active (28 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- BELINOSTATActive2018-01-05
- ROPIVACAINE HYDROCHLORIDE ANHYDROUSInactive2021-10-05
- RIBOCICLIB SUCCINATEInactive2020-09-10
- SUGAMMADEX SODIUMInactive2019-06-14
- ALECTINIB HYDROCHLORIDEInactive2019-06-12
- PLERIXAFORInactive2018-05-18
- IBRUTINIBInactive2017-05-12
- AFATINIB DIMALEATEInactive2016-12-31
- CARFILZOMIBInactive2016-01-30
- CHLORAMPHENICOL HEMISUCCINATEInactive2014-01-08
- BUPIVACAINE HYDROCHLORIDEInactive2012-12-28
- ROPIVACAINE HYDROCHLORIDEInactive2012-12-25
- BENDAMUSTINE HYDROCHLORIDEInactive2012-12-21
- TEMSIROLIMUSInactive2012-05-22
- DECITABINEInactive2011-12-16
- DOCETAXELInactive2011-07-20
- BUSULFANInactive2010-11-30
- CARBOPLATINInactive2010-07-30
- TOPOTECAN HYDROCHLORIDEInactive2009-01-06
- GEMCITABINE HYDROCHLORIDEInactive2008-04-22
- LETROZOLEInactive2008-01-15
- ANASTROZOLEInactive2007-07-06
- BICALUTAMIDEInactive2006-12-28
- OXALIPLATINInactive2006-07-17
- IRINOTECAN HYDROCHLORIDE TRIHYDRATEInactive2005-09-23
- DISODIUM PAMIDRONATEInactive2005-07-20
- PACLITAXEL SEMISYNTHETICInactive2004-12-30
- METAXALONEInactive1999-09-08
FDA compliance signals
30 FDA enforcement records linked to this company.
- 4832023-10-10
Scientifically sound laboratory controls
- 4832023-10-10
Procedures not in writing, fully followed
- 4832023-10-10
Written procedures not established/followed
- 4832023-10-10
Complete test data included in records
- 4832023-10-10
Environmental Monitoring System
- 4832023-10-10
Cleaning System
- 4832023-10-10
Following/documenting laboratory controls
- 4832023-10-10
Validation lacking for sterile drug products
- 4832023-10-10
Prepared for each batch, include complete information
- 4832023-10-10
Investigations of discrepancies, failures
- 4832023-10-10
Procedures for sterile drug products
- warning_letter2017-12-18
FDA Warning Letter (drug product)
- warning_letter2017-12-04
FDA Warning Letter (drug product)
- 4832015-05-22
SOPs not followed / documented
- 4832015-05-22
Cleaning / Sanitizing / Maintenance
- 4832015-05-22
Procedures for sterile drug products
- 4832015-05-22
Scientifically sound laboratory controls
- warning_letter2013-07-01
FDA Warning Letter (drug product)
- 4832012-08-28
Written program not followed
- 4832012-08-28
Cleaning / Sanitizing / Maintenance
- 4832012-08-28
Complete test data included in records
- 4832012-08-28
Cleaning/maintenance records not kept
- 4832012-08-28
Written procedures not established/followed
- 4832012-08-28
Test methods
- 4832012-08-28
Scientifically sound laboratory controls
- 4832012-08-28
Procedures for sterile drug products
- 4832012-08-28
Training , Education , Experience overall
- 4832012-08-28
SOPs not followed / documented
- 4832012-08-28
Procedures to be written and followed
- warning_letter2009-04-22
FDA Warning Letter (drug product)
Is this FRESENIUS KABI ONCOLOGY LTD?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.